Navigation Links
Step forward for nanotechnology: Controlled movement of molecules
Date:9/30/2009

Scientists in the United Kingdom are reporting an advance toward overcoming one of the key challenges in nanotechnology: Getting molecules to move quickly in a desired direction without help from outside forces. Their achievement has broad implications, the scientists say, raising the possibility of coaxing cells to move and grow in specific directions to treat diseases. It also could speed development of some long-awaited nanotech innovations. They include self-healing structures that naturally repair tears in their surface and devices that deliver medication to diseased while sparing healthy tissue. The study is scheduled for the October issue of ACS Nano, a monthly journal.

Mark Geoghegan and colleagues note long-standing efforts to produce directed, controlled movement of individual molecules in the nano world, where objects are about 1/50,000ththe width of a human hair. The main solutions so far have involved use of expensive, complex machines to move the molecules and they have been only partially successful, the scientists say.

The scientists used a special surface with hydrophobic (water repelling) and hydrophilic (water-attracting) sections. The region between the two sections produced a so-called "energy gradient" which can move tiny objects much like a conveyor belt. In lab studies, the scientists showed that plastic nanoparticles (polymer molecules) moved quickly and in a specific direction on this surface. "This could have implications in many technologies such as coaxing cells to move and grow in given directions, which could have major implications for the treatment of paralysis," the scientists said.


'/>"/>

Contact: Michael Woods
m_woods@acs.org
202-872-6293
American Chemical Society
Source:Eurekalert  

Page: 1

Related biology news :

1. Graduate Education in Physics: Which Way Forward?
2. Is hybridoma production about to take a quantum leap forward?
3. A step forward in virology
4. AVAC comments on NIAID decision not to move forward with PAVE 100 Trial
5. New step forward in search for solution to infection puzzle
6. Large-scale investment catapults CAMHs mental illness and addiction research forward
7. Forward planning release from the BA
8. New technique is quantum leap forward in understanding proteins
9. How to move agriculture forward with limited water
10. Moving gene therapy forward with mobile DNA
11. Clinical trials for shingles drug take an important step forward
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Step forward for nanotechnology: Controlled movement of molecules
(Date:4/11/2017)... Fla. , April 11, 2017 ... and secure authentication solutions, today announced that it ... Intelligence Advanced Research Projects Activity (IARPA) to develop ... Thor program. "Innovation has been a ... IARPA,s Thor program will allow us to innovate ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology: